Dibenzylcyclooctyne-PEG 4 -Fluor 545 was purchased from Jena Bioscience GmbH. All other reagents were purchased from Sigma-Aldrich or Fisher Scientific and were used without further purification. 2,5-Dibromohexanediamide was synthesized as reported by Davis. Nitrogen was used as the nebulizer and desolvation gas at a total flow of 600 L/h. Ion series were generated by integration of the total ion chromatogram (TIC) over the 3.4-4.8 min range. Total mass spectra for protein samples were reconstructed from the ion series using the pre-installed ProMass software using default settings for large proteins in m/z range 500-1500.
S-2 GFP(T230C,233Δ) was generated by ligation independent subcloning of superfolder GFP into pNIC28 Bsa4 using the primers:
5' -TACTTCCAATCCATGCGTAAAGGCGAAGAGCTGTTCAC -3' 5' -TATCCACCTTTACTGCTAACCATGACAGATGCCCGCTGCGGTTACG -3' GFP(S147C,T230C,233Δ) was generated by ligation independent subcloning of GFP(S147C) into pNIC28 Bsa4 using the primers:
5' -TACTTCCAATCCATGCGTAAAGGCGAAGAGCTGTTCAC -3' 5' -TATCCACCTTTACTGCTAACCATGACAGATGCCCGCTGCGGTTACG -3'
The vector was transformed into BL21(DE3)plysS cells, and proteins were expressed at 30 °C using standard methods. Proteins were purified by nickel chromatography, and the buffer was exchanged by repeated diafiltration into sodium phosphate (100 mM, pH 8.0) at 4 °C. Prior to analysis by LCMS, dithiothreitol (10 μL, 340 mM as a solution in water, 1000 equivalents per 100 μL of protein (1 mg/mL solution)) was added, the mixture incubated at 21 °C for 1 h and excess reducing agent was removed by repeated diafiltration with sodium phosphate (100 mM, pH 8.0).
Solvent accessibility calculations
Solvent accessibilities of α-protons in subtilisin and superfolder GFP were calculated using Naccess using the default parameters. 
Fluorescence measurements
Fluorescence properties were measured using a Cary Eclipse fluorescence spectrophotometer using 1 μM of fluorescent compound, in PBS pH 7.4 at 20 ºC. The sample was excited at 494 nm, and the emission intensity was scanned at 120 nm/min with an averaging time of 0.5 s and a data interval of 1 nm. The excitation and emission slits were set to 5 nm. Pre-treatment procedure Immediately prior to bioconjugation sequences, dithiothreitol (10 μL, 340 mM as a solution in water, 1000 equivalents per 100 μL of protein (1 mg/mL solution)) was added, incubated at 21 °C for 1 h and the excess reducing agent removed by repeated diafiltration into fresh buffer (100 mM sodium phosphate, pH 8.0) using VivaSpin sample concentrators (GE Healthcare, 10,000 MWCO).
S-3

Superfolder GFP
Sequence
S-12
Reaction of GFP with 2,5-dibromohexanediamide 4 2,5-Dibromohexanediamide (4, 10 μL, 17 mM solution in DMF, 50 equivalents) was added to a solution of GFP (100 μL, 1.0 mg/mL) in sodium phosphate (100 mM, pH 8.0) at 21 °C. The mixture was vortexed for 1 s, maintained at 37 °C for 2 h and analysed by LCMS. Intensity/a.u.
λ/nm
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S-16
Reaction of GFP(S147Sulf) with sodium azide 3 Sodium azide (10 μL, saturated solution in water) was added to GFP(S147Sulf) (100 μL, 1.0 mg/mL) in sodium phosphate (100 mM, pH 8.0) at 21 °C. The mixture was vortexed for 1 s, maintained at 37 °C for 2.5 h and analysed by LCMS. 
S-18
Reaction of GFP(T230C,233Δ) 6 with 2,5-dibromohexanediamide 4 2,5-Dibromohexanediamide (4, 10 μL, 17 mM solution in DMF, 50 equivalents) was added to a solution of GFP(T230C,233Δ) 6 (1.0 mg/mL) in sodium phosphate (100 mM, pH 8.0) at 21 °C. The mixture was vortexed for 1 s, maintained at 37 °C for 2.5 h and analysed by LCMS. 
S-22
Reaction of GFP(S147C,T230C,233Δ) 8 with 2,5-dibromohexanediamide 4 2,5-Dibromohexanediamide (4, 30 μL, 17 mM solution in DMF, 50 equivalents) was added to a solution of GFP(S147C,T230C,233Δ) 8 (300 μL, 1.0 mg/mL) in sodium phosphate (100 mM, pH 8.0) at 21 °C. The mixture was vortexed for 1 s, maintained at 37 °C for 2 h and analysed by LCMS. 
S-24
Reaction of GFP(S147Sulf, T230Dha, 233Δ) 9 with sodium azide Sodium azide (30 μL, saturated solution in water) was added to a solution of GFP(S147C,T230C,233Δ) 9 (300 μL, 1.0 mg/mL) in sodium phosphate (100 mM, pH 8.0) at 21 °C. The mixture was vortexed for 1 s, maintained at 37 °C for 2 h. Excess reagents were removed by repeated diafiltration into fresh buffer (100mM sodium phosphate, pH 8.0) using VivaSpin sample concentrators (GE Healthcare, 10,000 MWCO) and the mixture analysed by LCMS. 
S-26
Reaction of GFP(T230Dha,233Δ) 7 with sodium azide Sodium azide (10 μL, saturated solution in water) was added to a solution of GFP(T230C,233Δ) 7 (1.0 mg/mL) in sodium phosphate (100 mM, pH 8.0) at 21 °C. The mixture was vortexed for 1 s, and maintained at 37 °C for 4 h. Excess reagents were removed by repeated diafiltration into fresh buffer (100mM sodium phosphate, pH 8.0) using VivaSpin sample concentrators (GE Healthcare, 10,000 MWCO) and the mixture analysed by LCMS. 
S-28
Reaction of GFP(S147Azide,T230Dha,233Δ) 10 with dibenzylcyclooctyne-PEG 4 -Fluor 545
Dibenzylcyclooctyne-PEG 4 -Fluor 545 (10 μL, 34 mM solution in DMF, 100 equivalents) was added to a solution of GFP(S147Azide,T230Dha,233Δ) 10 (100 μL, 1.0 mg/mL) in sodium phosphate (100 mM, pH 8.0) at 21 °C. The mixture was vortexed for 1 s, maintained at 21 °C for 3.5 h. Excess reagents were removed by repeated diafiltration into fresh buffer (100mM sodium phosphate, pH 8.0) using VivaSpin sample concentrators (GE Healthcare, 10,000 MWCO) and the mixture analysed by LCMS. 
